Roche’s Tecen­triq scoops up a big win in small cell lung can­cer, grab­bing the lead in front­line cas­es

Roche’s Genen­tech has scored a land­mark suc­cess in treat­ing small cell lung can­cer, re­port­ing that its PD-L1 check­point Tecen­triq plus chemo helped pa­tients live longer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER